Search by Drug Name or NDC

    NDC 00169-3004-25 Novolin 100 [iU]/mL Details

    Novolin 100 [iU]/mL

    Novolin is a SUBCUTANEOUS INJECTION, SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is INSULIN HUMAN.

    Product Information

    NDC 00169-3004
    Product ID 0169-3004_652d3fd6-809f-476e-9159-a1beffb9ea01
    Associated GPIs 2710402000D320
    GCN Sequence Number 051292
    GCN Sequence Number Description insulin NPH human isophane INSULN PEN 100/ML (3) SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 18488
    HICL Sequence Number 000780
    HICL Sequence Number Description INSULIN NPH HUMAN ISOPHANE
    Brand/Generic Brand
    Proprietary Name Novolin
    Proprietary Name Suffix N
    Non-Proprietary Name Human Insulin
    Product Type HUMAN OTC DRUG
    Dosage Form INJECTION, SUSPENSION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN HUMAN
    Labeler Name Novo Nordisk
    Pharmaceutical Class Insulin [CS], Insulin [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA019959
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-3004-25 (00169300425)

    NDC Package Code 0169-3004-25
    Billing NDC 00169300425
    Package 5 SYRINGE, PLASTIC in 1 CARTON (0169-3004-25) / 3 mL in 1 SYRINGE, PLASTIC (0169-3004-12)
    Marketing Start Date 2019-09-06
    NDC Exclude Flag N
    Pricing Information N/A